In the assessment of 12-month price targets, analysts unveil insights for Exelixis, presenting an average target of $37.74, a high estimate of $45.00, and a low estimate of $29.00. Observing a 3.91% ...

Jason Holloway; Executive Vice President, Chief Revenue Officer; WidePoint Corp Robert George; Chief Financial Officer, Executive Vice President; WidePoint Corp Scott Buck; Analyst; H.C. Wainwright & ...

H.C. Wainwright analyst Amit Dayal lowered the firm’s price target on ClearSign (CLIR) to $2 from $6 and keeps a Buy rating on the shares. The ...